CDM codes

13066737 CDM codes with hospital pricing data in the network.

• CDM 510000086 — HC LACTATION, FACILITY E&M LEVEL 1 (2 hospitals, 33,828–33,864 samples)
• CDM 41899 — METRONIDAZOLE 1 % TOPICAL GEL (85 hospitals, 30,292–33,856 samples)
• CDM PX-4037706302 — HC Screen Digital Breast Tomosyn Bi (BCBS) (23 hospitals, 33,207–33,855 samples)
• CDM SUP-620-020 — KIT GRAFT BONE/SUB STIM 20ML (116 hospitals, 31,959–33,795 samples)
• CDM 30862 — FENTANYL (PF) 2 MCG/ML-BUPIVACAINE 0.125 %-NACL INJECTION SOLUTION (96 hospitals, 30,551–33,755 samples)
• CDM 27462 — ESTRADIOL 0.025 MG/24 HR WEEKLY TRANSDERMAL PATCH (73 hospitals, 30,551–33,755 samples)
• CDM 27474 — NITROGLYCERIN 0.4 MG/HR TRANSDERMAL 24 HOUR PATCH (137 hospitals, 30,551–33,755 samples)
• CDM 8300006 — Cbc W/Automated Differential (5 hospitals, 33,674–33,746 samples)
• CDM 106249 — NEOMYCIN 3.5 MG/G-POLYMYXIN B 10,000 UNIT/G-DEXAMETH 0.1 % EYE OINT (109 hospitals, 30,881–33,716 samples)
• CDM 122494 — SODIUM BICARBONATE 4.2 % INTRAVENOUS SOLUTION (NEO/PED) (62 hospitals, 31,147–33,694 samples)
• CDM 3428 — GENTAMICIN 0.3 % EYE DROPS (128 hospitals, 30,555–33,660 samples)
• CDM PX-403000006 — HC Scr Mammo Bi Incl Cad (17 hospitals, 33,147–33,660 samples)
• CDM PX-403000007 — HC Scr Mammo Uni Incl Cad (17 hospitals, 33,147–33,660 samples)
• CDM PX-7620000048 — Observation Ward (8 hospitals, 33,374–33,653 samples)
• CDM PX-7620000049 — HC Observation Ward - Carve Out (8 hospitals, 33,374–33,653 samples)
• CDM 121733 — IOVERSOL 320 MG IODINE/ML INTRAVENOUS SOLUTION (50 hospitals, 29,720–33,644 samples)
• CDM 28409 — ESTRADIOL 0.1 MG/24 HR WEEKLY TRANSDERMAL PATCH (104 hospitals, 30,539–33,635 samples)
• CDM 8878 — ZINC SULFATE 1 MG/ML INTRAVENOUS SOLUTION (114 hospitals, 30,536–33,605 samples)
• CDM 1900 — CUPRIC CHLORIDE 0.4 MG/ML INTRAVENOUS SOLUTION (42 hospitals, 30,747–33,600 samples)
• CDM 2332 — DEXAMETHASONE SODIUM PHOSPHATE 4 MG/ML INJECTION SOLUTION (159 hospitals, 17,182–33,571 samples)
• CDM 10987 — IOPAMIDOL 370 MG IODINE/ML (76 %) INTRAVENOUS SOLUTION (27 hospitals, 27,754–33,568 samples)
• CDM 9318 — BUPIVACAINE-EPINEPHRINE 0.5 %-1:200,000 INJECTION SOLUTION (72 hospitals, 30,545–33,560 samples)
• CDM HB_30081001000 — Manual urinalysis test with examination using microscope, automated (8 hospitals, 33,553 samples)
• CDM SUP-ITM-10132978 — GRAFT TISSUE 1.6 PLUS/MINUS .4MM MED HUMAN ALLODERM LG PERFORATED REGENERATIVE MATRIX IMPLANTABLE (6 hospitals, 33,506–33,524 samples)
• CDM SUP-ITM-10132981 — GRAFT TISSUE 1.6 SELECT DUO MED THICK HUMAN ALLODERM CONTOURED MED PERFORATED REGENERATIVE MATRIX (6 hospitals, 33,506–33,524 samples)
• CDM 131429 — NALOXONE 4 MG/ACTUATION NASAL SPRAY (31 hospitals, 29,830–33,520 samples)
• CDM 105646 — VALPROATE SODIUM 500 MG/5 ML (100 MG/ML) INTRAVENOUS SOLUTION (45 hospitals, 30,538–33,517 samples)
• CDM 128593 — HYDROCORTISONE-PRAMOXINE 2.5 %-1 % (4G) RECTAL CREAM (49 hospitals, 30,861–33,516 samples)
• CDM 10082 — FLUTICASONE PROPIONATE 0.05 % TOPICAL CREAM (63 hospitals, 30,527–33,515 samples)
• CDM 9921201 — PR OFFICE/OUTPATIENT ESTABLISHED SF MDM 10-19 MIN (11 hospitals, 32,745–33,510 samples)
• CDM PX-510000896 — HC VISIT EST PATIENT LEVEL 4 (16 hospitals, 30,430–33,490 samples)
• CDM 10648 — MOMETASONE 0.1 % TOPICAL OINTMENT (63 hospitals, 31,917–33,465 samples)
• CDM 11620 — UREA 40 % TOPICAL CREAM (171 hospitals, 30,733–33,460 samples)
• CDM 106349 — ONDANSETRON HCL 2 MG/ML INTRAVENOUS SOLUTION (109 hospitals, 22,273–33,460 samples)
• CDM 18217 — IODIXANOL 320 MG IODINE/ML INTRAVENOUS SOLUTION (28 hospitals, 29,099–33,455 samples)
• CDM PX-510000895 — HC VISIT EST PATIENT LEVEL 3 (16 hospitals, 30,491–33,443 samples)
• CDM PX-311000013 — HC FLOW CYTO EA ADD MARKER (34 hospitals, 32,378–33,440 samples)
• CDM PX-5109921301 — Fac Office/Outpatient Established Low Mdm (30 hospitals, 33,211–33,418 samples)
• CDM 28351 — AZELASTINE 0.05 % EYE DROPS (65 hospitals, 30,517–33,415 samples)
• CDM G0463 — HOSPITAL OUTPT CLINIC VISIT (38 hospitals, 33,378–33,414 samples)
• CDM 30100417 — HC AMINO ACIDS SGL QUAN EA SPEC (100 hospitals, 32,305–33,376 samples)
• CDM 63323-162-01 — KETOROLAC 30 MG/ML SOLN per 15 mg (7 hospitals, 32,656–33,376 samples)
• CDM 39278 — LEVALBUTEROL CONCENTRATE 1.25 MG/0.5 ML SOLUTION FOR NEBULIZATION (120 hospitals, 30,510–33,345 samples)
• CDM 10011 — FAMOTIDINE 20 MG TABLET (184 hospitals, 21,346–33,316 samples)
• CDM 3291 — FUROSEMIDE 10 MG/ML INJECTION SOLUTION (165 hospitals, 4,051–33,301 samples)
• CDM 19741 — METRONIDAZOLE 0.75 % TOPICAL GEL (115 hospitals, 30,505–33,295 samples)
• CDM 30857 — MVI,ADULT NO.4 WITH VIT K 3300 UNIT-150 MCG/10 ML INTRAVENOUS SOLUTION (62 hospitals, 30,505–33,295 samples)
• CDM 1703 — CITRIC ACID (BULK) POWDER (34 hospitals, 30,503–33,275 samples)
• CDM 9623 — CLINDAMYCIN 1 % TOPICAL GEL (66 hospitals, 30,503–33,275 samples)
• CDM 19711 — CLINDAMYCIN 1 % LOTION (79 hospitals, 30,501–33,255 samples)